Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01679210 · ClinicalTrials.gov registry record · NA

Study of a Postpartum Diabetes Prevention Program for Hispanic Women

A NA study, sponsored by University of Massachusetts, Amherst.

Completed
Registry status
NA
Development phase
263
Enrollment target

NCT01679210: Completed NA study, sponsored by University of Massachusetts, Amherst.

NCT01679210 is a NA study that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 263 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01679210, a NA study, has completed, sponsored by University of Massachusetts, Amherst.

COMPLETED
Registry status
NA
Development phase
263 participants
Enrollment target

Study Summary

The overall goal of this randomized controlled trial is to test the efficacy of a culturally and linguistically modified, individually-tailored lifestyle intervention to reduce risk factors for type 2 diabetes and cardiovascular disease among postpartum Hispanic women with a history of abnormal glucose tolerance during pregnancy.

Primary Outcome

Postpartum weight change will be measured as the difference between weight at 6 or 12 mos postpartum and weight at delivery. Weight will be measured on a digital scale.

Interventions

  • BEHAVIORAL Lifestyle Intervention

Trial Details

FieldValue
Enrollment Target 263 participants
Start Date 2013-01
Est. Completion 2018-06
Phase NA

What the finished NCT01679210 record still lists

NCT01679210 is an interventional study that assigns participants to a tested intervention. The registered 263 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which Lifestyle Intervention is the first listed.

NCT01679210 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01679210 about?

NCT01679210 is a clinical study titled "Study of a Postpartum Diabetes Prevention Program for Hispanic Women". The overall goal of this randomized controlled trial is to test the efficacy of a culturally and linguistically modified, individually-tailored lifestyle intervention to reduce risk factors for type 2 diabetes and cardiovascular disease among postpartum Hispanic women with a history of abnormal gluc...

What is the current status of trial NCT01679210?

This trial is currently completed. It is a NA study. The enrollment target is 263 participants. The study started on 2013-01. Estimated completion is 2018-06.

What interventions are being tested in trial NCT01679210?

The interventions under investigation include: Lifestyle Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01679210?

This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01679210's enrollment target sits among peer trials

263 396th of 2000 higher than 1,604 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04067336 · 263 participants · Phase 1

    First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

  • NCT06234423 · 263 participants · Phase 1

    A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

  • NCT06724627 · 263 participants · NA

    Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting

  • NCT04101669 · 264 participants · NA

    RESET System Pivotal Trial (Rev F)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01679210, the US trial registry maintained by the National Library of Medicine. NCT01679210 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.